Abstract
Vascular dementia is the second leading cause of dementia in the elderly. Sometimes the diagnosis is difficult because symptoms and causes are diverse. Although his treatment is a challenge for clinicians, prevention and early detection are the best strategies.
References
KALARIA RN, MAESTRE GE, ARIZAGA R, ET AL. Alzheimer’s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol 2008; 7:812-826.
NITRINI R, BOTTINO CM, ALBALA C, ET AL. Prevalence of dementia in Latin America: a collab- orative study of population-based cohorts. Int Psycho- geriatr 2009; 21:622-630.
OTT A, BRETELER MM, VAN HARSKAMP F, CLAUS JJ, VAN DER CAMMEN TJ, GROBBEE DE, HOFMAN A. Prevalence of Alzheimer’s disease and vascular dementia, association with education. The Rotterdam study, BMJ 1995; 310, 970–3.
HACHINSKI VC, LASSEN NA, MARSHALL J. Multi-infarct dementia: a cause of mental deteriora- tion in the elderly. Lancet 1974;2:207 – 10.
BOGOUSSLAVSKY J, VAN MELLE G, REGLI F. The Laussane Stroke Registry: Analysis of 1,000 Consecutive Patients with First Stroke. Stroke 1988; 19:1083-1092.
SCHMAHMANN J. Vascular Syndromes of Thala- mus. Stroke 2003; 34: 2264-2278.
LINDLEY R, WANG J, WONG M, MITCHELL P, LIEW G, HAND P, WARDLAW J, DE SILVA D, BAKER M, ROCHTCHINA E, CHEN C, HANKEY G, CHANG H, FUNG V, GOMES L, WONG T, ON BEHALF OF THE MULTI-CENTRE RETINA AND STROKE STUDY (MCRS) COLLABORATIVE GROUP. Retinal microvasculature in acute lacunar stroke: a cross-sectional study. Lancet Neurol 2009;8:628-634.
BABIKIAN V, ROPPER A. Binswanger´s Disease: A Review. Stroke 1987;18:2-12.
KINKEL W, JACOBS L, POLACHINI I, BATES V, HEFFNER R. Subcortical Arteriosclerotic Encephalopathy (Binswanger´s Disease). Arch Neurol 1985;42:951-959.
IADECOLA C, PARK L, CAPONE C. Threats to mind. Aging, amyloid and hypertension. Stroke 2009; 40 (Suppl1): S40-44.
ROMAN G. Brain hypoperfusion: a critical factor in vascular dementia: Neurol Res 2004;26:454-458.
ROYALL D. The “Alzheimerization” of dementia research. J Am Geriatr Soc 2003;51:277-278.
KNOPMAN D, Vascular Dementia. Continuum 2000; 113-133.
ROMÁN GC. Facts, myths, and controversies in vascular dementia. Journal of the Neurological Sciences 2004;226:49-52.
ROMÁN GC, TATEMICHI TK, ERKINJUNTTI T, CUMMINGS JL, MASDEU JC, GARCIA JH, ET AL. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250– 60.
CHUI HC, VICTOROFF JI, MARGOLIN D, JAGUST W, SHANKLE R, KATZMAN R. Crite- ria for the diagnosis of ischemic vascular demen- tia proposed by the state of California Alzheimer’s Disease diagnostic and treatment centers. Neurology 1992;42:473–80.
ROMÁN G, SACHDEV P, ROYALL D, BULLOCK R, ORGOGOZO J, LÓPEZ-POUSA S, ARIZAGA R, WALLIN A. Vascular cognitive disorder: a new cat- egoring updating vascular cognitive impairment and vascular dementia. Journal of the Neurological Sciences 2004;226:81-87
CHUI H, Vascular Cognitive Impairment: Today and tomorrow. Alzheimer´s & Dementia. 2006;2:185- 194.
MOORHOUSE P, ROCKWOOD K. Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurol 2008;7:246-255.
HACHINSKI V, POTTER P, MERSKEY H. Leuko-araiosis. Arch Neurol 1987;44:21-23.
PANTONI L, GARCÍA JH, Pathogenesis of Leu- koaraiosis. Stroke 1997;28:652-659.
STEINGART A, HACHISNKI V, LAU C, FOX AJ, DÍAZ F, CAPE R, LEE D, INZITARI D, MERSKEY H. Cognitive and Neurologic Findings in Subjects With Diffuse White Matter Lucencies on Computed Tomographic Scan (Leuko-araiosis) Arch Neurol 1987;44:32-35.
MATSUBAYASHI K, SHIMADA K, KAWA- MOTO A, OZAWA T. Incidental Brain Lesions on Magnetic Resonance Imaging and Neurobehavioral Functions in the Apparently Healthy Elderly. Stroke 1992;23:175-180.
YIKLOSKI R, YIKLOSKI A, ERKINJUTTI T, SULKAVA R, RAININKO R, TILVIS R. Arch Neurol 1993;50:818-824
FERRO JM, MADUREIRA S. Age-ralated white matter changes and cognitive impairment. Journal of the Neurological Sciences 2002;203-204:221-225.
A VISWANATHAN, H CHABRIAT Cerebral microhemorrhage. Stroke 2006; 37:550-555.
THANVI B, ROBINSON T. Sporadic cerebral amyloid angiopathy – an important cause of cere- bral haemorrhage in older people. Age and Ageing 2006;35:565-571.
DICHGANS M, MAYER M, UTTNER I, BRÜNING R, MÜLLER-HÖCKER. RUNGGER G, EBKE M, KLOCKGETHER, GASSER T. The Phenotypici Spectrum of CADASIL: Clinical Findings in 102 Cases. Ann Neurol 1998;44:731-739.
HANON O, FORETTE F. Treatment of hyper- tension and prevention of dementia. Alzheimer´s & Dementia 2005;1:30-37.
FORETTE F, SEUX L, STAESSEN JA, THIJS L, BIRKENHAGER WH, BABARSKIENE MR, ET AL. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998;352:1347–51.
FORETTE F, SEUX L, STAESSEN J, THIJS L, BABARSKIENE M, BABEANU S, ET AL. Sys- tolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hyper- tension in Europe (Syst-Eur) study. Arch Intern Med 2002;162:2046 –52.
TZOURIO C, ANDERSON C, CHAPMAN N, WOODWARD M, NEAL B, MAC-MAHON S, ET AL. PROGRESS Collaborative Group. Effects of Blood pressure lowering with perindopril and inda- pamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003;163:1069 –75.
BOSCH J, YUSUF S, POGUE J, SLEIGHT P, LONN E, RANGOONWALA B, ET AL. HOPE Investigators. Heart outcomes prevention evaluation. Use of ramipril in preventing stroke: double blind randomised trial. BMJ 2002;324:699 –702.
LITHELL H, HANSSON L, SKOOG I, ELM- FELDT D, HOFMAN A, OLOFSSON B, ET AL. SCOPE Study Group. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 2003;21:875– 86.
SACCO RL, DIENER HC, YUSUF ET AL. Aspi- rin and Extended- Release Dypiridamole versus Clopidogrel for Recurrent Stroke. N Eng J Med 2008;359: 1-14.
ERKINJUTTI T, KURZ A, GAUTHIER S, BULL- OCK R, LILIENFELD S, DAMARAJU C. Efficacy of galantamina inprobable vascular dementia, and Alzheimer´s disease combined with cerebrovascular disease: a randomised trial
KUMAR V, ANAND R, MESSINA J, HARTMAN, R, VEACH J. An efficacy and safety analysis of Exelon in Alzheimer’s disease with concurrent vascu- lar risk factors. Eur J Neurol 2000; 7: 159–69.
KAVIRAJAN H, SCHNEIDER L. Efficacy and adverse effects of cholinesterase inhibitors and meman- tine in vascular dementia: a meta-analysis of randomised controlled trials. Lancet Neurol 2007; 6:782-792.
ORGOGOZO JM, RIGAUD AS, STOFFL ER A, ET AL. Effi cacy and safety of memantine in patients with mild to moderate vascular dementia: a random- ized, placebo-controlled trial (MMM 300). Stroke 2002; 33: 1834–39.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.